Healthcare Industry News: Geistlich Pharma
News Release - April 10, 2018
Geistlich Bio-Gide(R) Portfolio ExpandsThe Collagen Expert, Geistlich Biomaterials Launches Two NEW Resorbable Collagen Membranes to Enhance Clinical Procedures
PRINCETON, N.J., April 10, 2018 -- (Healthcare Sales & Marketing Network) -- Geistlich Pharma North America, Inc., introduces Geistlich Bio-Gide® Compressed and Geistlich Bio-Gide® Shape to its portfolio of resorbable collagen membranes.
"Geistlich Bio-Gide® Compressed combines alternative handling with the proven outstanding biofunctionality of Geistlich biomaterials, allowing surgeons more choice for their membranes" – Dr. István Urbán
Learn More about Geistlich Bio-Gide® Compressed by clicking here: https://www.geistlich-na.com/en-us/professionals/membranes/bio-gide-compressed/user-benefits/
"Geistlich Bio-Gide® Shape is a user-friendly, resorbable collagen membrane that can easily be implemented in the management of post-extraction sites for ridge preservation."
– Dr. Daniele Cardaropoli
Learn More about Geistlich Bio-Gide® Shape by clicking here: https://www.geistlich-na.com/en-us/professionals/membranes/bio-gide-shape/user-benefits/
Indications for Use:
Geistlich Bio-Gide® Compressed is indicated for the following uses: Augmentation around implants placed in immediate or delayed extraction sockets, localized ridge augmentation for later implantation, alveolar ridge reconstruction for prosthetic treatment, filling of bone defects after root resection, cystectomy and removal of retained teeth, guided bone regeneration in dehiscence defects and guided tissue regeneration procedures in periodontal defects.
Geistlich Bio-Gide® Shape is indicated for the following uses: Augmentation around implants placed in immediate or delayed extraction sockets; localized ridge augmentation for later implantation; alveolar ridge reconstruction for prosthetic treatment; filling of bone defects after root resection; cystectomy and removal of retained teeth and guided bone regeneration in dehiscence defects.
About Geistlich Pharma North America, Inc. -
With over 160 years of collagen expertise, Geistlich Biomaterials continues to lead regeneration through its expanding portfolio of dental regenerative biomaterials: Geistlich Bio-Oss®, the leading bone substitute for regenerative dentistry, Geistlich Bio-Gide®, the leading collagen membrane for oral tissue regeneration and Geistlich Mucograft®, a specifically designed collagen matrix for soft-tissue regeneration. Our dedication to scientific collaboration and commitment to successful treatment outcomes are what makes Geistlich Biomaterials, Exactly Like No Other.
- iData Research Inc., US Dental Bone Graft Substitutes and other Biomaterials Market, 2011.
- iData Inc., European Dental Bone Graft Substitutes and other Biomaterials Market, 2012.
Source: Geistlich Pharma
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.